Repare Therapeutics Inc. RPTX
Set alert
2.65 USD 0.00 0.00%
At close · Jan 28
2.64 -0.01 -0.37%
After hours · Jan 28, 4:00 PM ET
2.65 Day range 2.65
52-week range unavailable
- YTD
- +1.92%
- 1 year
- +130.43%
- Open
- 2.65
- Prev close
- 2.65
- Mkt cap
- 57.39M
- Vol
- 1.17M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.65
- High
- 2.65
- Forward P/E
- -0.45
- Beta
- 0.71
- Short ratio
- 4.57
- Inst. own
- 83.62%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2024
- 50-d avg
- 3.10
- 200-d avg
- 3.47
- 1y target
- 8.50
Ownership
Held by insiders 0.95%
Held by institutions 83.62%
Float held by institutions 84.42%
Institutions 71
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| BVF Inc. | 24.31% | 10,333,600 | 13.95M | Sep 29, 2024 |
| Blue Owl Capital Holdings LP | 7.93% | 3,372,499 | 4.55M | Sep 29, 2024 |
| Orbimed Advisors LLC. | 7.82% | 3,322,488 | 4.49M | Sep 29, 2024 |
| Versant Venture Management, LLC | 6.23% | 2,646,657 | 3.57M | Sep 29, 2024 |
| ARK Investment Management, LLC | 5.90% | 2,509,737 | 3.39M | Sep 29, 2024 |
| MPM Asset Management, LLC | 5.28% | 2,242,636 | 3.03M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK ETF Tr-ARK Genomic Revolution ETF | 5.73% | 2,435,100 | 3.29M | Oct 30, 2024 |
| Vanguard Health Care Index Fund | 0.13% | 55,241 | 74.58K | Aug 30, 2024 |
| ETF Series Solutions-Range Cancer Therapeutics ETF | 0.08% | 35,575 | 48.03K | Aug 30, 2024 |
| Avantis U.S. Small Cap Equity ETF | 0.07% | 28,571 | 38.57K | Sep 29, 2024 |
| SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF | 0.05% | 20,209 | 27.28K | Sep 29, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.04% | 19,128 | 25.82K | Oct 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BVF PARTNERS L P | Beneficial Owner of more than 10% of a Class of Security | Purchase | Nov 15, 2023 | 0 |
| FORTE STEVE | Chief Financial Officer | Sale | Mar 31, 2024 | 44,775 |
| KOEHLER MARIA | Officer | Sale | Mar 31, 2024 | 231,409 |
| SEGAL LLOYD MITCHELL | Chief Executive Officer | Sale | Mar 31, 2024 | 0 |
| ZINDA MICHAEL | Officer | Sale | Mar 31, 2024 | 71,908 |